Trial site
Cancer Center of Kansas
- 20running trials
- 10closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Colorectal cancer5 trials
- Gastric and oesophageal cancer3 trials
- Head and neck cancer3 trials
- Metastatic breast cancer3 trials
- Childhood cancers2 trials
- Follicular lymphoma2 trials
- Myeloproliferative neoplasms2 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Chronic myeloid leukaemia1 trial
- and 7 more
- Phase
- Phase 314 trials
- Phase 29 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting13 trials
- Recruiting7 trials
- Completed6 trials
- Terminated4 trials
- Lead sponsor
- Alliance Foundation Trials, LLC.2 trials
- Celgene2 trials
- Eli Lilly and Company2 trials
- Hoffmann-La Roche2 trials
- Janssen Research & Development, LLC2 trials
- and 20 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Completed
Completed
Terminated
Completed
Terminated
Completed
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
Site data: ClinicalTrials.govUpdated 17 Nov 2026